NIH Awards U of Maryland $3.7M for Personalized Medicine Program in Monogenic Diabetes | GenomeWeb

NEW YORK (GenomeWeb) – The University of Maryland School of Medicine announced it has been awarded a four-year, $3.7 million grant from the National Institutes of Health to develop a personalized medicine program for the diagnosis and treatment of monogenic diabetes.

The National Human Genome Research Institute and the Implementing Genomics in Practice network is providing the funding for the project.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.